Skip to search formSkip to main contentSkip to account menu

Alveofact

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2004
Review
2004
Sir: The study by Baroutis and coworkers contains several important inaccuracies, the sum of which combine to cast doubt on the… 
2004
2004
Sir: In response to your letter, I would like to thank you for the opportunity to express our opinion. Our paper on the… 
2003
2003
The importance of steroids given antenatally to the mothers in prevention of the respiratory distress syndrome (RDS) is… 
2002
2002
Abstract Background : The respiratory distress syndrome (RDS) in premature newborns has been etiologically correlated to immature… 
1999
1999
Incorporation of surfactant into polymerizing fibrin causes loss of surface activity and marked retardation of clot lysis by… 
1997
1997
Background: 2 treatment strategies to compare GE and LM in artificial RDS after lavage (paO2 constantly < 13 kPa; lung compliance… 
1996
1996
AIM After registration of the bovine Surfactant Alveofact (Fa. Thomae) for treatment of neonatal respiratory distress syndrome… 
1995
1995
ABSTRACT: Newborn infants with respiratory distress who fail to respond to surfactant treatment receive a second dose of… 
1994
1994
Background: Both surfactant (SF) deficiency, anomalies in synthesis and inactivation are major pathophysiological features of… 
1993
1993
Severe deterioration of surfactant function is noted under conditions of plasma protein leakage into the alveolar space; moreover…